Hyperphosphatemia has a key role in the progression of kidney disease. It leads to secondary hyperparathyroidism and affects erythropoiesis in patients with CKD. In human medicine, high serum phosphorus levels are significantly associated with vascular calcification and increase of morbidity and mortality. Hence, oral phosphate binders become fundamental therapeutic aids. Among them, a free calcium and alluminum molecula, lanthanum carbonate, has been recently introduced also in veterinary medicine.
Trattamento dell'iperfosforemia: il target terapeutico nella Chronic Kidney Disease / P. Scarpa, T. Vitiello. - In: PRAXIS VETERINARIA. - ISSN 0350-4441. - 31:2(2010 Jun), pp. 14-18.
Trattamento dell'iperfosforemia: il target terapeutico nella Chronic Kidney Disease
P. ScarpaPrimo
;T. VitielloUltimo
2010
Abstract
Hyperphosphatemia has a key role in the progression of kidney disease. It leads to secondary hyperparathyroidism and affects erythropoiesis in patients with CKD. In human medicine, high serum phosphorus levels are significantly associated with vascular calcification and increase of morbidity and mortality. Hence, oral phosphate binders become fundamental therapeutic aids. Among them, a free calcium and alluminum molecula, lanthanum carbonate, has been recently introduced also in veterinary medicine.
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
